SETX Gene Ataxia-Oculomotor Apraxia Type 2 NGS Genetic DNA Test

Introduction

The SETX Gene Ataxia-Oculomotor Apraxia Type 2 NGS Genetic DNA Test is a vital diagnostic tool designed to identify genetic mutations associated with neurological disorders. This test employs Next-Generation Sequencing (NGS) technology to provide a comprehensive analysis of the SETX gene, which is linked to ataxia and oculomotor apraxia. Understanding your genetic predisposition can significantly impact your treatment and management options.

What the Test Measures

This genetic test measures mutations in the SETX gene, which are responsible for Ataxia-Oculomotor Apraxia Type 2. By analyzing the DNA, the test can detect specific genetic variations that may lead to neurological symptoms.

Who Should Consider This Test

Individuals experiencing symptoms such as:

• Uncoordinated movements (ataxia)
• Difficulties with eye movement (oculomotor apraxia)
• Family history of neurological disorders
• Progressive loss of motor skills

Patients with risk factors for genetic neurological disorders should consider this test for a clearer understanding of their condition.

Benefits of Taking the Test

• Accurate diagnosis of genetic conditions
• Informed decision-making regarding treatment options
• Ability to provide targeted therapies based on genetic findings
• Family planning insights through genetic counseling

Understanding Your Results

Results from the SETX Gene Ataxia-Oculomotor Apraxia Type 2 NGS Genetic DNA Test will typically be available within 3 to 4 weeks. A genetic counselor will help interpret the findings, guiding you through the implications of the results and potential next steps.

Test Pricing

Convenience Across Kenya

We have branches across all major cities in Kenya, and we also offer a home sample collection service for your convenience. Book your test today by calling or WhatsApp at +254711564616.